Arrival & Registration
Exclusive educational launch meeting
Event agenda
Advancing Acromegaly Care: Optimising Treatment for Better Outcomes
Agenda preview
Our co-Chairs for the day are Professor Stephanie E. Baldeweg, Dr Simon Aylwin and Professor Mark Gurnell, who will be joined by an international faculty including Professor Diego Ferone and Professor Márta Korbonits.
The meeting will bring together leading experts and a patient perspective to explore the evolving management of acromegaly, with a focus on sharing clinical insights and experiences from across the field.
The full programme and agenda will be available soon.
Tuesday 24th November 2026
Full event agenda
Meeting: 10:00–16:00 | Registration: 09:30 | Audience: Consultant Endocrinologist
Welcome & Introductions
Co-Chairs:
Dr Simon Aylwin
Professor Stephanie E Baldeweg and Professor Mark Gurnell
Who is the acromegaly patient?
- Patient interview - briefly describe what it is like to live with acromegaly and their experience with medical interventions they have received
Patient speaker interviewed by one of the Co-chairs
Co-chair 1 to introduce Prof Aled Rees
Understanding Tumour Characteristics to Guide Acromegaly Management
- Describe the anatomy of pituitary tumours
- Explore which factors at work up can predict response to surgery and therapy
- Discuss in-practice remission rates post-surgery by size and shape of tumour
Prof Aled Rees
Co-chair 1 to introduce Prof Niki Karavitaki
From Guidelines to Practice: Applying Acromegaly Recommendations in the UK
- A brief overview of relevant consensus guidelines for managing acromegaly and associated symptoms
- How to apply the guidelines in UK clinical practice
Prof Niki Karavitaki
Panel discussion / Q&A
Co-chair 1 to host session for Prof Aled Rees and Prof Niki Karavitaki
Mid-morning refreshment break
Mid-morning refreshment break
Co-chair 2 to introduce Prof Diego Ferone
Pasireotide in Practice: Evidence, Outcomes and Patient Management
- Showcase the clinical efficacy data for pasireotide, balanced by the relevant safety data
- Highlight differentiators – impact on headaches, tumour mass etc.
- How to manage treatment-induced hyperglycaemia
Prof Diego Ferone
Who is the right patient for Signifor in the UK?
Dr Simon Aylwin
Panel discussion / Q&A
Co-chair 2 to host session for Prof Diego Ferone
Lunch
Co-chair 3 to introduce Prof Miles Levy
Managing headache in acromegaly: recognition, assessment and treatment considerations
- Review the typical presentation of headaches in acromegaly
- Explore the treatment options available including the clinical evidence behind these
Prof Miles Levy
Co-chair 3 to introduce Prof Marta Korbonits
Personalised medicine in acromegaly: Matching therapy to patient needs and characteristics
- Therapeutic options for managing acromegaly
Biomarkers for predicting response
Prof Márta Korbonits
Panel discussion / Q&A
Co-chair 3 to host session for Prof Miles Levy and Prof Márta Korbonits
Mid-afternoon refreshment break
Mid-afternoon refreshment break
Co-chair 2 to introduce Dr Aparna Pal and Prof Diego Ferone
Real-world acromegaly management: Case-based insights from clinical practice
- Interactive case-based discussion
- Present complex patient cases including:
- A case where SIGNIFOR was used and successful following intolerance to established treatment (Simon)
- A case where a physician wanted to prescribe SIGNIFOR but was not able to (TBD)
- Challenge audience re management considerations with MCQ voting
- Weave the NHS policy for Signifor into one of the cases as an option to address treatment inertia
Dr Aparna Pal to lead
Prof Diego Ferone as additional expert
Panel discussion and Q&A
Co-chair 2 to host session for Prof Diego Ferone and Dr Aparna Pal
Summary & Close
Co-Chairs:
Dr Simon Aylwin
Professor Stephanie E Baldeweg and Professor Mark Gurnell
Join us in London on 24th November 2026
Places are limited, so early registration is recommended.